Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
NSAIDS	O
(Non-Steroidal	O
Anti-Inflammatory	O
Drug)	O
/	O
vancomycin	O
Attending:	O
___	O
Chief	O
Complaint:	O
elective	O
admission	O
for	O
chemo	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
PRIMARY	O
ONCOLOGIST:	O
___	O
___	O
DIAGNOSIS:	O
Stage	O
IV	O
DLBCL	O
TREATMENT	O
REGIMEN:	O
R-CHOP	O
(s/p	O
3	O
cycles)	O
+	O
1	O
cycle	O
HD	O
MTX	O
CHIEF	O
COMPLAINT:	O
Scheduled	O
Chemotherapy	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS:	O
___	O
PMH	O
of	O
Crohns	O
(asymptomatic	O
since	O
dx),	O
Osteoporosis	O
(c/b	O
L2	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fx),	B-Vertebral_compression_fracture
Bladder/Ureteral	O
Ca	O
(s/p	O
surgery/mitomycin/BCG	O
___	O
yrs	O
ago),	O
Stage	O
IV	O
DLBCL	O
(on	O
R-CHOP)	O
presented	O
for	O
cycle	O
2	O
of	O
CNS	O
ppx	O
with	O
high	O
dose	O
MTX	O
Patient	O
noted	O
that	O
felt	O
well	O
prior	O
to	O
this	O
admission,	O
and	O
is	O
eating,	O
drinking,	O
voiding,	O
stooling	O
without	O
issue.	O
He	O
noted	O
that	O
he	O
has	O
not	O
had	O
fever	O
or	O
chills.	O
Denied	O
acute	O
complaint.	O
Noted	O
that	O
he	O
took	O
his	O
bicarbonate	O
tablets	O
as	O
directed	O
prior	O
to	O
this	O
admission.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
As	O
per	O
last	O
oncology	O
note	O
by	O
Dr	O
___	O
"He	O
has	O
a	O
very	O
long	O
history	O
of	O
osteoporosis	O
for	O
which	O
he	O
has	O
been	O
on	O
multiple	O
medications	O
over	O
the	O
past	O
___	O
years.	O
He	O
developed	O
worsening	O
back	O
pain	O
with	O
a	O
new	O
L2	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
in	O
___.	O
He	O
subsequently	O
has	O
developed	O
pains	O
intermittently	O
on	O
both	O
sides	O
of	O
his	O
chest	O
wall.	O
His	O
appetite	O
diminished	O
approximately	O
2	O
months	O
ago	O
but	O
has	O
since	O
improved	O
a	O
bit.	O
He	O
has	O
lost	B-Weight_loss
20	O
pounds	B-Weight_loss
compared	O
to	O
last	O
fall	O
and	O
he	O
has	O
developed	O
a	O
new	O
anemia	O
associated	O
with	O
an	O
elevated	O
sedimentation	O
rate	O
and	O
a	O
polyclonal	O
increase	O
in	O
his	O
gammaglobulins.	O
An	O
MRI	O
of	O
his	O
lumbar	O
spine	O
last	O
week	O
showed	O
a	O
diffusely	O
abnormal	O
bone	O
marrow	O
signal	O
worrisome	O
for	O
malignancy	O
or	O
an	O
erythropoietic	O
disorder.	O
He	O
does	O
have	O
a	O
history	O
of	O
bladder	O
and	O
ureteral	O
cancer	O
diagnosed	O
___	O
years	O
ago	O
and	O
treated	O
both	O
surgically	O
and	O
with	O
mitomycin-C	O
and	O
several	O
infusions	O
of	O
BCG.	O
Recent	O
urologic	O
evaluation	O
has	O
not	O
shown	O
any	O
recurrent	O
disease;	O
however	O
a	O
CT	O
urogram	O
done	O
in	O
___	O
did	O
show	O
2	O
new	O
round	O
splenic	O
lesions,	O
the	O
largest	O
of	O
which	O
was	O
2.3	O
cm.	O
There	O
was	O
no	O
adenopathy	O
or	O
any	O
other	O
significant	O
abnormality	O
in	O
his	O
abdomen	O
noted.	O
He	O
was	O
briefly	O
treated	O
with	O
prednisone	O
when	O
the	O
possibility	O
of	O
polymyalgia	O
was	O
raised	O
but	O
this	O
was	O
stopped	O
after	O
obtaining	O
the	O
results	O
of	O
his	O
MRI.	O
His	O
rib	O
pains	O
and	O
back	O
pains	O
were	O
much	O
better	O
while	O
on	O
the	O
steroids.	O
Physical	O
examination	O
was	O
unremarkable	O
other	O
than	O
very	O
thin	O
and	O
kyphosis.	O
No	O
adenopathy	O
or	O
splenomegaly	O
noted.	O
Labs	O
show	O
mild	O
anemia,	O
elevated	O
LDH	O
(477).	O
BM	O
performed	O
-	O
dry	O
tap	O
but	O
core	O
signed	O
out	O
as	O
diffuse	O
large	O
B	O
cell	O
lymphoma.	O
___:	O
Repeat	O
BM	O
for	O
cytogenetics	O
with	O
core	O
sent	O
in	O
RPMI;	O
FISH	O
on	O
4	O
cells	O
showed	O
FISH:	O
LOW	O
POSITIVE	O
for	O
GAIN	O
of	O
BCL6	O
and	O
MYC.	O
3-4%	O
of	O
the	O
interphase	O
bone	O
marrow	O
cells	O
examined	O
had	O
an	O
extra	O
intact	O
BCL6	O
signal	O
and	O
an	O
extra	O
intact	O
MYC	O
signal.	O
These	O
findings	O
were	O
in	O
large	O
cells	O
and	O
are	O
likely	O
due	O
to	O
trisomy	O
or	O
partial	O
trisomy	O
of	O
chromosomes	O
3	O
and	O
8,	O
which	O
are	O
common	O
cytogenetic	O
findings	O
in	O
lymphoma.	O
There	O
was	O
no	O
evidence	O
of	O
the	O
IGH/BCL2	O
gene	O
rearrangement	O
or	O
rearrangements	O
of	O
the	O
BCL6	O
and	O
MYC	O
genes	O
in	O
this	O
limited	O
bone	O
marrow	O
aspirate	O
and	O
bone	O
core	O
sample.	O
___:	O
PET	O
scan	O
showed	O
1.	O
Diffuse	O
FDG	O
avid	O
osseous	O
lesions	O
involving	O
the	O
axial	O
and	O
appendicular	O
skeleton,	O
largest	O
involving	O
the	O
left	O
iliac	O
bone	O
with	O
soft	O
tissue	O
extension	O
through	O
the	O
cortical	O
margin	O
putting	O
the	O
patient	O
at	O
risk	O
of	O
pathologic	O
fracture.	O
In	O
the	O
spine,	O
soft	O
tissue	O
extent	O
is	O
greatest	O
at	O
the	O
T10	O
level.	O
If	O
neurologic	O
symptoms,	O
consider	O
MRI	O
to	O
assess	O
for	O
canal	O
narrowing/cord	O
involvement.	O
2.	O
Multiple	O
splenic	O
lesions	O
and	O
a	O
single	O
hepatic	O
lesion	O
concerning	O
for	O
lymphomatous	O
involvement.	O
3.	O
Incidental	O
4mm	O
right	O
lower	O
lobe	O
pulmonary	O
nodule.	O
Recommend	O
attention	O
___:	O
First	O
cycle	O
Rit/CHOP	O
chemo	O
with	O
split	O
dose	O
Rituxan,	O
plan	O
for	O
HD	O
MTX	O
day	O
14.	O
.___:	O
Hosp'd	O
___	O
x3d	O
for	O
fever,	O
neutropenia	O
with	O
mild	O
GI	O
upset,	O
neg	O
CT	O
scans.	O
Counts	O
recovered	O
quickly.	O
Sent	O
home	O
on	O
Flagyl,	O
cipro.	O
The	O
plan	O
of	O
day	O
___	O
MTX	O
was	O
therefore	O
aborted.	O
___:	O
cycle	O
2	O
R-CHOP,	O
neulasta	O
___	O
___:	O
cycle	O
1	O
high	O
dose	O
methotrexate	O
3.5	O
g/m2	O
for	O
CNS	O
prophylaxis	O
anticipated	O
at	O
___	O
___:	O
C3	O
R-chop,	O
with	O
neulasta	O
due	O
___.	O
Dev'd	O
urticaria	O
with	O
adriamycin	O
-	O
resolved	O
with	O
steroids.	O
___:	O
Brief	O
admission	O
to	O
___	O
for	O
fever,	O
neutropenia.	O
Cults	O
negative.	O
Counts	O
recovered	O
quickly.	O
___:	O
Cycle	O
4	O
Rit/CHOP"	O
PAST	O
MEDICAL	O
HISTORY:	O
-Osteoporosis	O
-Crohn's	O
-Gallbladder	O
stones	O
-L2	I-Vertebral_compression_fracture
Compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
-History	O
of	O
bladder	O
cancer	O
and	O
ureteral	O
cancer:	O
diagnosed	O
___	O
years	O
ago	O
and	O
treated	O
both	O
surgically	O
and	O
with	O
mitomycin-C	O
and	O
several	O
infusions	O
of	O
BCG	O
Social	O
History:	O
___	O
Family	O
History:	O
Alzheimer's	B-Dementia
in	O
his	O
mother;	O
CAD/PVD	O
in	O
his	O
father;	O
CVA	O
in	O
his	O
father;	O
Cancer	O
in	O
his	O
father	O
and	O
mother;	O
___	O
-	O
Type	O
II	O
in	O
his	O
father	O
and	O
paternal	O
grandfather;	O
___	O
in	O
his	O
mother;	O
___	O
in	O
his	O
mother.	O
Physical	O
Exam:	O
VITAL	O
SIGNS:	O
0753	O
Temp:	O
98.3	O
PO	O
BP:	O
124/61	O
HR:	O
72	O
RR:	O
18	O
O2	O
sat:	O
96%	O
O2	O
delivery:	O
RA	O
General:	O
NAD	O
HEENT:	O
MMM,	O
no	O
thrush,	O
no	O
OP	O
lesions	O
CV:	O
RR,	O
NL	O
S1S2	O
no	O
S3S4,	O
no	O
MRG	O
PULM:	O
CTAB,	O
respirations	O
unlabored	O
ABD:	O
BS+	O
SNT/ND	O
LIMBS:	O
No	O
___,	O
WWP	O
SKIN:	O
No	O
rashes	O
on	O
extremities	O
NEURO:	O
Speech	O
fluent,	O
strength	O
grossly	O
intact	O
PSYCH:	O
thought	O
process	O
logical,	O
linear,	O
future	O
oriented	B-Delirium
ACCESS:	O
chest	O
port	O
site	O
intact	O
w/o	O
erythema	O
Pertinent	O
Results:	O
___	O
07:28PM	O
BLOOD	O
WBC-5.0	O
RBC-2.76*	O
Hgb-8.0*	O
Hct-25.9*	O
MCV-94	O
MCH-29.0	O
MCHC-30.9*	O
RDW-17.7*	O
RDWSD-61.1*	O
Plt	O
___	O
___	O
07:28PM	O
BLOOD	O
Glucose-130*	O
UreaN-9	O
Creat-0.8	O
Na-143	O
K-4.3	O
Cl-102	O
HCO3-33*	O
AnGap-8*	O
___	O
07:28PM	O
BLOOD	O
ALT-21	O
AST-29	O
___	O
07:28PM	O
BLOOD	O
Calcium-8.1*	O
Phos-2.6*	O
Mg-1.8	O
___	O
07:28PM	O
BLOOD	O
mthotrx-0.14	O
___	O
07:00PM	O
BLOOD	O
mthotrx-1.8*	O
Brief	O
Hospital	O
Course:	O
Dr	O
___	O
is	O
a	O
___	O
Crohn's	O
(asymptomatic	O
since	O
dx),	O
Osteoporosis	O
(c/b	O
L2	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fx),	B-Vertebral_compression_fracture
Bladder/Ureteral	O
Ca	O
(s/p	O
surgery,	O
mitomycin/BCG),	O
Stage	O
IV	O
DLBCL	O
(on	O
R-CHOP)	O
presented	O
for	O
C2	O
HD	O
MTX	O
for	O
CNS	O
ppx.	O
He	O
tolerated	O
chemotherapy	O
well	O
w/o	O
any	O
AE.	O
Had	O
anticipated	O
hypokalemia	O
and	O
hypophosphatemia	O
which	O
were	O
repleted.	O
No	O
changes	O
were	O
made	O
to	O
his	O
medications.	O
His	O
TCP/Anemia	O
were	O
stable.	O
Discharged	O
home	O
w/o	O
services.	B-Has_carers
Will	O
f/u	O
in	O
clinic	O
for	O
chemo	O
as	O
scheduled.	O
>30	O
min	O
spent	O
coordinating	O
care	O
for	O
discharge.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
LORazepam	O
0.5	O
mg	O
PO	O
DAILY:PRN	O
anxiety	O
2.	O
Ondansetron	O
4	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
3.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
4.	O
Sodium	O
Bicarbonate	O
1300	O
mg	O
PO	O
ASDIR	O
5.	O
Sulfameth/Trimethoprim	O
DS	O
1	O
TAB	O
PO	O
3X/WEEK	O
(___)	O
Discharge	O
Medications:	O
1.	O
LORazepam	O
0.5	O
mg	O
PO	O
DAILY:PRN	O
anxiety	O
2.	O
Ondansetron	O
4	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
3.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
4.	O
Sodium	O
Bicarbonate	O
1300	O
mg	O
PO	O
ASDIR	O
5.	O
Sulfameth/Trimethoprim	O
DS	O
1	O
TAB	O
PO	O
3X/WEEK	O
(___)	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Stage	O
IV	O
DLBCL	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dr	O
___	O
tolerated	O
your	O
chemotherapy	O
well.	O
Please	O
follow	O
up	O
with	O
your	O
oncology	O
team	O
as	O
scheduled.	O
Followup	O
Instructions:	O
___	O

